More Globe Newswire

View Older Stories View Newer Stories

Dec 9, 2025 08:00AM 23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer
Dec 9, 2025 08:00AM Eric Herrera Named to Forbes 30 Under 30 for Driving Innovation in Critical Element Extraction Across Energy and Industrial Sectors
Dec 9, 2025 08:00AM Bion and Kimmeridge Execute Memorandum of Understanding
Dec 9, 2025 08:00AM BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision
Dec 9, 2025 08:00AM Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Dec 9, 2025 08:00AM Arqit Quantum Inc. Announces Financial Results for Fiscal Year 2025
Dec 9, 2025 08:00AM Gaxos Enters Multibillion-Dollar Digital Faith Market with Launch of Bible Pray AI
Dec 9, 2025 08:00AM PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
Dec 9, 2025 08:00AM Parallel’s Breakthrough Teletherapy Platform and High-Support Clinical Model Drive 98 Percent of Students to Meet or Exceed IEP Goals
Dec 9, 2025 08:00AM Payscale Identifies the Fastest Growing and Most At-Risk Jobs Heading Into 2026
Dec 9, 2025 08:00AM Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System
Dec 9, 2025 08:00AM BBSI Opens Nashville Branch Office, Expanding Its Southern Presence
Dec 9, 2025 08:00AM Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Dec 9, 2025 07:56AM Form 8.3 - Avadel Pharmaceuticals plc
Dec 9, 2025 07:53AM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Richmond Mutual Bancorporation, Inc. (Nasdaq – RMBI), Sealed Air Corporation (NYSE – SEE), Movano Inc. (Nas
Dec 9, 2025 07:45AM Prosafe SE: Mandatory notification of trade
Dec 9, 2025 07:45AM ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector
Dec 9, 2025 07:34AM Solar A/S: No. 19 2025 Major shareholder announcement
Dec 9, 2025 07:33AM Danske Bank A/S, transactions by persons discharging managerial responsibilities
Dec 9, 2025 07:30AM REPEAT – QGold to Host Live Webinar to Discuss Corporate Update
Dec 9, 2025 07:30AM Revival Gold Provides Update and Latest Results From Drilling at the Mercur Gold Project in Utah
Dec 9, 2025 07:30AM AGF Management Limited Declares Fourth Quarter 2025 Dividend
Dec 9, 2025 07:30AM Menlo Ventures’ 2025 State of Generative AI Report: Enterprise Investment Hit $37B in 2025, Tripling in One Year
Dec 9, 2025 07:30AM NanoXplore Announces Nima Moghimian as Chief Technology Officer
Dec 9, 2025 07:30AM Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
Dec 9, 2025 07:30AM Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company
Dec 9, 2025 07:30AM BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Dec 9, 2025 07:30AM GURU Organic Energy Continues Its Record-Breaking Streak on Amazon During Black Friday-Cyber Monday
Dec 9, 2025 07:30AM Edible Garden Preliminary Sales Results During Key Thanksgiving Time Period Increased 26.9% in 2025
Dec 9, 2025 07:30AM Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
Dec 9, 2025 07:30AM BitMEX Integrates Mercuryo On-ramp to Introduce Fiat-to-Crypto Conversion
Dec 9, 2025 07:25AM Bitget Launchpool adds Stable (STABLE) with over 47.8M in Token Rewards
Dec 9, 2025 07:23AM DoorDash Chief Analytics Officer Breaks Down Insights from the “State of Local Commerce” Report on YourUpdateTV
Dec 9, 2025 07:20AM Asmodee - Pre Stabilization Notice
Dec 9, 2025 07:20AM Exodus Movement, Inc. November 2025 Treasury Update and Monthly Metrics
Dec 9, 2025 07:17AM Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
Dec 9, 2025 07:15AM 1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years
Dec 9, 2025 07:12AM Hacken Releases MEXC’s Audit, Confirms Full Asset Backing and Strengthened Transparency Standards
Dec 9, 2025 07:05AM Heineken® 0.0 x LÕK serve up the world’s first padel racket with a built-in bottle opener
Dec 9, 2025 07:01AM Digital Culture Group Dominates Awards Season With Wins in AI Innovation
Dec 9, 2025 07:00AM Aya Gold & Silver Reports High-Grade Silver Results at Zgounder
Dec 9, 2025 07:00AM Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Dec 9, 2025 07:00AM Gencor Releases Fourth Quarter and Fiscal Year 2025 Results
Dec 9, 2025 07:00AM Harfang and SOQUEM Expand Gold Footprint at Menarik West, Québec
Dec 9, 2025 07:00AM CRML Executes Term-Sheet for 50/50 Joint Venture With EU and NATO Member, Romania, Creating a Fully Integrated Mine-to-Processing Supply Chain for Long-Term Security for the European Manufacturing &am
Dec 9, 2025 07:00AM Parex Resources Announces Update on Discussions with GeoPark Regarding a Potential Business Combination
Dec 9, 2025 07:00AM Premier American Uranium Files Technical Report for Cebolleta Uranium Project
Dec 9, 2025 07:00AM Asante Gold Provides Update on Bibiani Sulphide Treatment Plant Ramp-Up
Dec 9, 2025 07:00AM TopBuild Hosting 2025 Investor Day on December 9, Providing Strategic Outlook on Business
Dec 9, 2025 07:00AM ONL Therapeutics Announces Publication of Data from Phase 1b Study of Xelafaslatide, an Investigational Therapy for Geographic Atrophy, in Ophthalmology Science
View Newer Stories View Older Stories